Corvus Pharmaceuticals Inc (CRVS)
R&D Expense Growth
42.85%
Quarterly · Period ending:
CRVS R&D Expense Growth
Latest reported42.85%period ending
Latest reported42.85%period ending
CRVS Quarterly R&D Growth (QoQ) (0.00% → 42.85%)
Latest values, visible window
High-resolution chart · PNG
CRVS r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 42.8546% | |
| 12.4359% | |
| 17.5656% | |
| 7.3797% | |
| 5.6353% | |
| 24.7573% | |
| 14.4006% | |
| 26.9324% | |
| 0.9571% | |
| 1.9005% | |
| 0.8575% | |
| -0.0756% | |
| -13.6265% | |
| 12.598% | |
| -60.6368% | |
| 110.5424% | |
| -3.4706% | |
| 6.5163% | |
| -31.5119% | |
| -23.2264% | |
| 10.644% | |
| 14.4486% | |
| 8.6418% | |
| -15.7567% | |
| -22.6902% | |
| 13.935% | |
| -0.8448% | |
| -15.4511% | |
| 12.9632% | |
| 12.2111% | |
| 0.2388% | |
| -13.8034% | |
| -19.7306% | |
| 24.9277% | |
| -9.7363% | |
| -13.3457% | |
| -8.2315% | |
| 47.8151% | |
| 18.4767% | |
| 8.2596% | |
| 31.9066% | |
| 9.9409% | |
| 95.2665% | |
| 25.3865% | |
| 4.21% | |
| 4,541.1772% | |
| 0% |